We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
-12.93%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$1.12B
AUM Growth
-$229M
Cap. Flow
-$31.9M
Cap. Flow %
-2.86%
Top 10 Hldgs %
34.45%
Holding
269
New
3
Increased
30
Reduced
109
Closed
14

Top Buys

Rank Stock Value
1
MTNB icon
Matinas BioPharma
MTNB
+$1.32M
2
DVN icon
Devon Energy
DVN
+$1.06M
3
BXMT icon
Blackstone Mortgage Trust
BXMT
+$877K
4
PANW icon
Palo Alto Networks
PANW
+$788K
5
ON icon
ON Semiconductor
ON
+$414K

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$5.04M
2
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$4.79M
3
PYPL icon
PayPal
PYPL
+$4.3M
4
AAPL icon
Apple
AAPL
+$1.4M
5
AMZN icon
Amazon
AMZN
+$1.17M

Sector Composition

Rank Sector Weight
1 Healthcare 21.76%
2 Technology 21.22%
3 Industrials 12.3%
4 Financials 11.58%
5 Communication Services 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FLS icon
176
Flowserve
FLS
$10.2B
$401K 0.04%
14,005
– –
LOW icon
177
Lowe's Companies
LOW
$125B
$399K 0.04%
2,286
– –
FCX icon
178
Freeport-McMoran
FCX
$97.5B
$394K 0.04%
13,451
-4,030
-23% -$161K
LLY icon
179
Eli Lilly
LLY
$1.06T
$389K 0.03%
1,200
– –
AWK icon
180
American Water Works
AWK
$26.9B
$387K 0.03%
2,600
-100
-4% -$15.2K
AMGN icon
181
Amgen
AMGN
$222B
$373K 0.03%
1,530
– –
TDG icon
182
TransDigm Group
TDG
$67.7B
$373K 0.03%
695
– –
GIS icon
183
General Mills
GIS
$19.7B
$370K 0.03%
4,907
– –
ZBH icon
184
Zimmer Biomet
ZBH
$18.4B
$368K 0.03%
3,500
– –
LHX icon
185
L3Harris
LHX
$53.4B
$367K 0.03%
1,517
-25
-2% -$6.04K
ET icon
186
Energy Transfer Partners
ET
$69.3B
$349K 0.03%
34,972
– –
NRT
187
North European Oil Royalty Trust
NRT
$81M
$344K 0.03%
27,999
– –
L icon
188
Loews
L
$23.6B
$336K 0.03%
5,670
– –
ECL icon
189
Ecolab
ECL
$79.9B
$329K 0.03%
2,135
– –
HPE icon
190
Hewlett Packard
HPE
$70.5B
$319K 0.03%
24,050
– –
ACGL icon
191
Arch Capital
ACGL
$33.6B
$315K 0.03%
6,930
– –
NVO
192
Novo Nordisk
NVO
$209B
$312K 0.03%
5,600
-16,490
-75% -$915K
TRV icon
193
Travelers Companies
TRV
$80.2B
$300K 0.03%
1,775
– –
ADM icon
194
Archer Daniels Midland
ADM
$36.9B
$279K 0.03%
3,600
– –
NVDA icon
195
NVIDIA
NVDA
$5.42T
$277K 0.02%
18,300
– –
GNRC icon
196
Generac Holdings
GNRC
$12.5B
$273K 0.02%
1,295
-325
-20% -$79.9K
PEG icon
197
Public Service Enterprise Group
PEG
$37.7B
$271K 0.02%
4,284
– –
ORI icon
198
Old Republic International
ORI
$10.4B
$262K 0.02%
11,720
– –
HSY icon
199
Hershey
HSY
$36.6B
$258K 0.02%
1,200
– –
STT icon
200
State Street
STT
$50.7B
$256K 0.02%
4,150
– –
6 7
8
9 10

Similar funds

BGCP
Bristol Gate Capital Partners Toronto, Ontario, Canada $1.55B AUM 12.75% 1-Year Est. Return
MSA
MUFG Securities Americas New York $1.55B AUM 28.4% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
CCM
Cinctive Capital Management New York $1.53B AUM 48.83% 1-Year Est. Return
TNBTD
Trustmark National Bank Trust Department Jackson, Mississippi $1.56B AUM 16.53% 1-Year Est. Return
MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return

Neville Rodie & Shaw's Q2 2022 Portfolio in Review

As of Q2 2022, Neville Rodie & Shaw held 269 positions worth $1.12B, down 17% from $1.35B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Neville Rodie & Shaw's Q2 2022 filing shows 3 new, 30 increased, 109 reduced and 14 closed positions. Its largest new stake was Warner Bros: 14,427 shares worth $194K. The largest sale was ExxonMobil, an estimated $5.04M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

  • Neville Rodie & Shaw's largest Q2 2022 buy was Warner Bros: 14,427 shares worth $194K.
  • Neville Rodie & Shaw added most to Matinas BioPharma in Q2 2022, an estimated $1.32M increase.
  • Neville Rodie & Shaw's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $5.04M.
  • Neville Rodie & Shaw fully exited Cerner Corp in Q2 2022, selling an estimated $752K.
  • Neville Rodie & Shaw's ten largest holdings make up 34% of its $1.12B portfolio in Q2 2022.
  • Neville Rodie & Shaw opened 3 new positions and closed 14 in Q2 2022.
  • Neville Rodie & Shaw's portfolio value fell 17% quarter-over-quarter to $1.12B.

Based on Neville Rodie & Shaw's 13F filing for Q2 2022, filed 6 Jul 2022.